Inactivation of aspartic transcarbamylase in sporulating Bacillus subtilis: demonstration of a requirement for metabolic energy.
The aspartic transcarbamylase (ATCase) activity of Bacillus subtilis cells disappears rapidly from stationary-phase cells prior to sporulation. ATCase activity does not appear in the culture fluid during the stationary phase; hence the enzyme appears to be inactivated in the cells. The enzyme is inactivated normally in two different mutants lacking proteases; the activity is very stable in crude extracts of cells or in the culture fluid. These results suggest that ATCase is not inactivated by the general proteolysis that occurs in sporulating bacteria. The inactivation of ATCase can be completely inhibited after it has begun by oxygen starvation or addition of fluoroacetate. Inhibitors of oxidative phosphorylation and electron transport also interrupt the inactivation of ATCase. The inactivation of ATCase is very slow in two mutant strains that are deficient in enzymes of tricarboxylic acid cycle. Addition of gluconate to stationary cultures of the mutant strains, which is known to restore depleted adenosine 5'-triphosphate pools in these bacteria, also restores inactivation of ATCase. These experiments support the conclusion that the generation of metabolic energy is necessary for the inactivation of ATCase in stationary cells. ATCase activity is stable in growing cells in which ATCase synthesis is repressed by addition of uracil; the enzyme is inactivated normally, however, when such cells cease growing.
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D001221:Aspartate Carbamoyltransferase / Q000378:metabolism*; D001412:Bacillus subtilis / Q000201:enzymology* / Q000254:growth & development / Q000378:metabolism; D002247:Carbon Isotopes; D002474:Cell-Free System; D002701:Chloramphenicol / Q000494:pharmacology; D002952:Citric Acid Cycle; D004794:Enzyme Repression; D005463:Fluoroacetates / Q000494:pharmacology; D005942:Gluconates / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D009154:Mutation; D010101:Oxygen Consumption; D010447:Peptide Hydrolases / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology; D013170:Spores / Q000201:enzymology*; D013171:Spores, Bacterial / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism; D014475:Uncoupling Agents / Q000494:pharmacology
D002247:Carbon Isotopes; D005463:Fluoroacetates; D005942:Gluconates; D014475:Uncoupling Agents; D002701:Chloramphenicol; D000255:Adenosine Triphosphate; D001221:Aspartate Carbamoyltransferase; D010447:Peptide Hydrolases; D012293:Rifampin